159 related articles for article (PubMed ID: 7655743)
21. Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation.
Karges W; Dralle H; Raue F; Mann K; Reiners C; Grussendorf M; Hüfner M; Niederle B; Brabant G;
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):52-8. PubMed ID: 14758572
[TBL] [Abstract][Full Text] [Related]
22. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules.
Costante G; Meringolo D; Durante C; Bianchi D; Nocera M; Tumino S; Crocetti U; Attard M; Maranghi M; Torlontano M; Filetti S
J Clin Endocrinol Metab; 2007 Feb; 92(2):450-5. PubMed ID: 17119000
[TBL] [Abstract][Full Text] [Related]
23. Androgen receptor expression in C-cells and in medullary thyroid carcinoma.
Zhai QH; Ruebel K; Thompson GB; Lloyd RV
Endocr Pathol; 2003; 14(2):159-65. PubMed ID: 12858007
[TBL] [Abstract][Full Text] [Related]
24. Influence of laminin substratum on cell proliferation and CALC I gene expression in medullary thyroid carcinoma C cell lines.
Lekmine F; Lausson S; Pidoux E; Segond N; Roos B; Treilhou-Lahille F; Jeanne A
Mol Cell Endocrinol; 1999 Nov; 157(1-2):181-9. PubMed ID: 10619409
[TBL] [Abstract][Full Text] [Related]
25. Relevance of immunocytochemistry on thin-layer cytology in thyroid lesions suspicious for medullary carcinoma: a case-control study.
Rossi ED; Raffaelli M; Mulè A; Zannoni GF; Pontecorvi A; Santeusanio G; Minimo C; Fadda G
Appl Immunohistochem Mol Morphol; 2008 Dec; 16(6):548-53. PubMed ID: 18685492
[TBL] [Abstract][Full Text] [Related]
26. Circulating calcitonin and carcinoembryonic antigen m-RNA detected by RT-PCR as tumour markers in medullary thyroid carcinoma.
Bojunga J; Dragan C; Schumm-Draeger PM; Usadel KH; Kusterer K
Br J Cancer; 2001 Nov; 85(10):1546-50. PubMed ID: 11720443
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of procalcitonin measurement in patients after total thyroidectomy due to medullary thyroid carcinoma.
Bolko P; Manuszewska-Jopek E; Michałek K; Waśko R; Jaskuła M; Sowiński J
Arch Immunol Ther Exp (Warsz); 2003; 51(6):415-9. PubMed ID: 14692663
[TBL] [Abstract][Full Text] [Related]
28. Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels.
Giraudet AL; Vanel D; Leboulleux S; Aupérin A; Dromain C; Chami L; Ny Tovo N; Lumbroso J; Lassau N; Bonniaud G; Hartl D; Travagli JP; Baudin E; Schlumberger M
J Clin Endocrinol Metab; 2007 Nov; 92(11):4185-90. PubMed ID: 17726071
[TBL] [Abstract][Full Text] [Related]
29. Effect of octreotide on expression of calcitonin gene in cultured cells of medullary thyroid carcinoma.
Zabel M
Histol Histopathol; 2004 Jul; 19(3):793-7. PubMed ID: 15168342
[TBL] [Abstract][Full Text] [Related]
30. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
[TBL] [Abstract][Full Text] [Related]
31. "Atypical" medullary thyroid carcinoma with little or no calcitonin expression.
Schmid KW; Ensinger C
Virchows Arch; 1998 Sep; 433(3):209-15. PubMed ID: 9769123
[TBL] [Abstract][Full Text] [Related]
32. Sporadic medullary thyroid carcinoma associated with toxic multinodular goitre.
Small PK; Smith D
J R Coll Surg Edinb; 1997 Jun; 42(3):199-200. PubMed ID: 9195818
[TBL] [Abstract][Full Text] [Related]
33. [Thyroid C cells and their pathology: Part 2: Medullary thyroid carcinoma].
Synoracki S; Schmid ST; Ting S; Schmid KW
Pathologe; 2015 May; 36(3):254-60. PubMed ID: 25917773
[TBL] [Abstract][Full Text] [Related]
34. Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests.
Scheuba C; Kaserer K; Weinhäusl A; Pandev R; Kaider A; Passler C; Prager G; Vierhapper H; Haas OA; Niederle B
Surgery; 1999 Dec; 126(6):1089-95; discussion 1096. PubMed ID: 10598192
[TBL] [Abstract][Full Text] [Related]
35. A monoclonal antibody against rat calcitonin inhibits the growth of a rat medullary thyroid carcinoma cell line in vitro.
Zhang R; DeGroot LJ
Endocrinology; 1997 Apr; 138(4):1697-703. PubMed ID: 9075733
[TBL] [Abstract][Full Text] [Related]
36. In-situ analysis of calcitonin and CGRP expression in medullary thyroid carcinoma.
Boultwood J; Wynford-Thomas D; Richards GP; Craig RK; Williams ED
Clin Endocrinol (Oxf); 1990 Sep; 33(3):381-90. PubMed ID: 2253409
[TBL] [Abstract][Full Text] [Related]
37. Gallium-68 Dotatate PET/CT is superior to other imaging modalities in the detection of medullary carcinoma of the thyroid in the presence of high serum calcitonin.
Tran K; Khan S; Taghizadehasl M; Palazzo F; Frilling A; Todd JF; Al-Nahhas A
Hell J Nucl Med; 2015; 18(1):19-24. PubMed ID: 25679074
[TBL] [Abstract][Full Text] [Related]
38. Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients.
Yen TW; Shapiro SE; Gagel RF; Sherman SI; Lee JE; Evans DB
Surgery; 2003 Dec; 134(6):890-9; discussion 899-901. PubMed ID: 14668720
[TBL] [Abstract][Full Text] [Related]
39. Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: A multicenter study.
Papi G; Corsello SM; Cioni K; Pizzini AM; Corrado S; Carapezzi C; Fadda G; Baldini A; Carani C; Pontecorvi A; Roti E
J Endocrinol Invest; 2006 May; 29(5):427-37. PubMed ID: 16794366
[TBL] [Abstract][Full Text] [Related]
40. Calculation and validation of a plasma calcitonin limit for early detection of medullary thyroid carcinoma in nodular thyroid disease.
Rink T; Truong PN; Schroth HJ; Diener J; Zimny M; Grünwald F
Thyroid; 2009 Apr; 19(4):327-32. PubMed ID: 19355822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]